Blueprint Medicines Corp (BPMC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Sales | 65,977 | 36,547 | 62,731 | 107,021 | 24,188 |
| Cost of Goods | 4,665 | 7,031 | 8,344 | 12,081 | 7,059 |
| Gross Profit | 61,312 | 29,516 | 54,387 | 94,940 | 17,129 |
| Operating Expenses | 186,254 | 187,185 | 160,535 | 411,157 | 134,284 |
| Operating Income | -124,277 | -157,638 | -105,804 | -316,136 | -117,096 |
| Interest Expense | 8,396 | 0 | 0 | 0 | 0 |
| Other Income | 396 | 1,059 | -11 | 83 | 30 |
| Pre-tax Income | -132,277 | -156,579 | -105,815 | -316,053 | -117,066 |
| Income Tax | 886 | 3,130 | 184 | 2,633 | 175 |
| Net Income Continuous | -133,163 | -159,709 | -105,999 | -318,686 | -117,241 |
| Net Income | $-133,163 | $-159,709 | $-105,999 | $-318,686 | $-117,241 |
| EPS Basic Total Ops | -2.23 | -2.68 | -1.79 | -5.43 | -2.00 |
| EPS Basic Continuous Ops | -2.23 | -2.68 | -1.79 | -5.43 | -2.00 |
| EPS Diluted Total Ops | -2.23 | -2.68 | -1.79 | -5.43 | -2.00 |
| EPS Diluted Continuous Ops | -2.23 | -2.68 | -1.79 | -5.43 | -2.00 |
| EBITDA(a) | $-121,812 | $-156,168 | $-104,176 | $-313,112 | $-115,480 |